Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel camptothecin derivatives with enhanced stability and antitumor activity

April 14, 2004

KS-119, a potential hypoxic cell cytotoxin

April 14, 2004

ON-1910Na effective against human liver cancer in vivo

April 14, 2004

FASgen receives NCI grant to support study of FAS inhibitors

April 13, 2004

Novel Bcl-XL antagonist effective against chemoresistant cancers in vivo

April 13, 2004

Enhanced tumor cytotoxicity with novel DNA-PK inhibitor

April 13, 2004

Novel small molecule tubulin inhibitor by Zentaris

April 13, 2004

New gossypol analogues and their use in cancer therapy reported by CNRS

April 13, 2004

MediGene extends clinical development of Polyphenon E to actinic keratosis

April 13, 2004

NeoRx acquires rights to AMD-473 from AnorMED

April 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...